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Abstract 
Introduction 
Socioeconomic disparities are associated with the prevalence of disability in the general population; however, it is 
unknown whether a similar association exists between socioeconomic status and disability from chronic kidney disease 
(CKD, defined as albuminuria or an estimated glomerular filtration rate of 15-59 mL/min/1.73 m ). 
Methods 
A total of 4,257 US adults aged 20 years or older with CKD who participated in the National Health and Nutrition 
Examination Survey 1999-2008 completed standardized questionnaires assessing self-reported difficulties in activities 
of daily living (ADL), instrumental ADL (IADL), lower-extremity mobility (LEM), and leisure and social activities 
(LSA). We used multivariable logistic regression with population-based weighting to obtain adjusted prevalence 
estimates of disability by demographic, socioeconomic, health care access, and clinical characteristics. 
Results 
Participants with less education had more disability (age- and sex-adjusted prevalence of disability by lowest vs highest 
level of education: ADL, 24.5% vs 16.9%; IADL, 34.0% vs 20.3%; LEM, 56.9% vs 44.6%; LSA, 26.2% vs 16.8%; P < .001 
for all). We observed similar trends for income. After further adjustment for other sociodemographic factors, health 
care access, and comorbid conditions, education and income both remained significantly associated, by any measure, 
with lower prevalence of disability. 
Conclusion 
Among people with CKD in the United States, lower socioeconomic status is associated with greater risk of disability, 
independent of race/ethnicity, health care access, and comorbid conditions. Our findings suggest that people with CKD 
and limited education or lower income should be targeted for early intervention to limit disability and further loss of 
income, both of which could worsen outcomes in CKD. 
Introduction 
Disability, as measured by reduced physical functioning (1,2), frailty (3,4), and decreased cognitive functioning (5-8), is 
commonly reported among people with chronic kidney disease (CKD) and end-stage renal disease. Socioeconomic 
disparities in both the development and progression of CKD have also been well described (9-12). Socioeconomic 
factors have been associated with disability in the general population, but this relationship has not been studied among 
people with CKD (13). Identification of socioeconomic status as an independent risk factor for disability in people with 
CKD, beyond the high risk conferred by CKD and its risk factors, would provide a means for early identification of 
those at risk and, possibly, intervention. 
Race/ethnicity and other factors that contribute to socioeconomic status (SES), including income and education, could 
affect both CKD and disability through multiple pathways (Figure). Environmental and personal factors could lead to 
both CKD and disability; risk factors for CKD and disability, including diabetes and hypertension, could also be heavily 
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influenced by the same factors. Such risk factors could lead directly to disability or could lead to CKD, which in turn 
could lead to disability through complications of CKD. Additionally, older age is strongly associated with both CKD and 
disability and could lead to disability directly or through increased presence and severity of comorbid conditions or 
increased use of medications with age. Finally, disability could affect modifiable sociodemographic factors, particularly 
income, if the disability interferes with work (14). 
 
Figure. Pathways from socioeconomic and demographic factors to chronic kidney disease and disability. Solid arrows 
indicate likely paths; dashed arrows indicate possible paths. [A text description of this figure is also available.] 
Our primary objective was to establish whether a socioeconomic (defined as education level and household income) 
disparity exists in the prevalence of self-reported disability among noninstitutionalized US adults with CKD, 
independent of the unique complexity of this disease, which involves many coexisting factors that may contribute to 
disability. Our secondary objective was to compare these associations with the association of race/ethnicity and 
disability. We also explored whether age and the severity of CKD modified the association of disability with SES and 
compared our findings in people with CKD and people without CKD. 
Methods 
Study design  
The National Health and Nutrition Examination Survey (NHANES) is an ongoing annual survey conducted by the 
National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention. NHANES consists of a 
standardized in-home interview and a physical examination at a mobile examination center (MEC). Data from 
NHANES consist of representative samples of noninstitutionalized, nonmilitary US residents. All survey participants 
give written informed consent, and the NHANES protocol is approved by the NCHS research ethics review board. 
We used 1999-2008 NHANES data. We limited our analysis to 4,305 NHANES participants aged 20 years or older 
whose serum creatinine, urinary creatinine, and urinary albumin measurements indicated CKD. We excluded 
participants who did not respond to the physical functioning questionnaire (n = 9), had a low estimated glomerular 
filtration rate (eGFR) (<15 mL/min/1.73 m ) (n = 39), or were pregnant (n = 0 after other exclusions), which gave us a 
final sample of 4,257. 
Measurements 
As part of the home interview, participants are asked via the computer-assisted personal interviewing system about 
physical function limitations: difficulty performing activities of daily living (ADL) (eg, getting in and out of bed; using a 
fork, cup or knife; dressing), instrumental ADL (IADL) (eg, managing money, performing house chores, preparing 
meals), lower-extremity mobility (LEM) (eg, walking a mile, walking up 10 steps, stooping, kneeling or crouching, 
walking between rooms on the same floor, standing up from an armless chair), and leisure and social activities (LSA) 
(eg, going to the movies, attending social events, leisure activity at home) (15). 
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status (education, income), health care access (health insurance, routine source of care), health conditions (self-
reported diagnosis of diabetes, hypertension, cardiovascular disease [CVD], cancer, and arthritis), and physical activity 
during the health examinations. Study interviewers record prescription medications from prescription bottles provided 
by the participant. As part of the MEC examination, health care providers measure height, weight, and systolic and 
diastolic blood pressure (average of ≥3 auscultatory measurements). Providers also collect serum and urine samples. 
In accordance with the NHANES study protocol (http://www.cdc.gov/nchs/nhanes/nhanes2007-
2008/lab_methods_07_08.htm), laboratory personnel at various sites measure serum creatinine, urinary creatinine, 
urinary albumin, and hemoglogin and assess C-reactive protein from frozen samples. 
Definitions  
We defined disability as a report of “some” or greater difficulty in at least 1 of the activities in the ADL, IADL, LSA, or 
LEM domains. 
We defined CKD as either reduced kidney function or elevated albuminuria. We calculated eGFR according to the 
modified Modification of Diet in Renal Disease Study equation for calibrated creatinine (16). We defined albuminuria 
as a urinary albumin-to-creatinine ratio (ACR) of at least 30 mg/g. We defined CKD stages as stages 1 and 2 (eGFR 
≥60 mL/min/1.73 m  and ACR ≥30 mg/g on single measurement [evidence of kidney damage]) and stages 3 and 4 
(eGFR 15-59 mL/min/1.73 m  on single measurement [evidence of reduced kidney function, with or without kidney 
damage]). 
We defined self-reported diabetes, CVD, cancer, and arthritis by an answer of yes to the question, “Have you ever been 
told by a doctor or other health professional that you have (disease or condition)?” We further defined self-reported 
CVD by an answer of yes to the question, “Have you ever been told by a doctor or other health professional that you 
have coronary artery disease, angina, myocardial infarction, stroke, or congestive heart failure?” We defined 
hypertension by an answer of yes to the question, “Have you ever been told by a health professional that you have 
hypertension?” or by measured systolic or diastolic blood pressure of at least 140 or 90 mm Hg, respectively; obesity by 
a body mass index (calculated from measured height and weight and reported in kg/m ) of at least 30; anemia by a 
hemoglobin of less than 12 g/dl (women) or less than 14 g/dL (men); and inflammation by a C-reactive protein level of 
at least 1 mg/dL. We categorized physical activity by whether participants self-reported activity levels that they 
perceived to be higher, the same, or lower than those of their peers. 
Statistical analyses  
We summarized selected characteristics and compared excluded participants with those included in the study by these 
characteristics. We calculated adjusted prevalence estimates and P values using multivariable logistic regression 
models and estimated variance of proportions by using Taylor-series linearization. We chose adjustment variables, 
including sociodemographic characteristics (age, sex, race/ethnicity, education, income), health care access factors 
(insurance, routine site for health care), and clinical conditions (diabetes, hypertension, obesity, cardiovascular 
disease, cancer, and arthritis), based on their demonstrated strong association with disability and sociodemographic 
characteristics or a priori belief that they were confounding factors in the association of disability with CKD. We 
conducted sensitivity analyses using subgroups of interest, based on age and CKD severity, with further covariates; we 
explored interaction terms among sociodemographic measures and compared results with those of people without 
CKD (n = 16,898). We performed all analyses using the survey commands in Stata version 10.0 (StataCorp, LP, College 
Station, Texas), accounting for study design weights, strata, and primary sampling units. Significance was set at P 
< .05. 
Results 
Characteristics of study population  
Among the 4,257 participants with evidence of CKD (85.4%), the mean age was 61 years, and most participants were 
female, non-Hispanic white, US-born, and married (Table 1). Most (61.0%) had an annual income less than $45,000, 
although most had an income above the federal poverty level. Most were insured and had a routine site for health care. 
Comorbid conditions were common, particularly hypertension, arthritis, obesity, cardiovascular disease, and diabetes 
(Table 1). Participants were evenly divided by CKD severity. Excluded participants (n = 48) were significantly more 
likely to be nonwhite, to be unmarried, to be nonobese, and to have hypertension, compared with included 
participants.  
Prevalence of disability 
The prevalence of reported disability was high among adults with CKD; 1 in 5 reported limitations in ADL after 
adjustment for age and sex (Table 2). The highest prevalence was for LEM (50.0%). Higher levels of education and 
income (measured as annual household income or as a percentage of the federal poverty level) were associated with 
lower prevalence of disability among all measures examined. Country of birth was associated with prevalence of 
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Prevalence of disability was higher in the non-Hispanic black and Mexican American populations compared to non-
Hispanic whites only for ADL. 
With full adjustment for other sociodemographic, health care access, and clinical variables, prevalence of disability was 
not associated with race/ethnicity with the exception of ADL disability, which was higher in nonwhite participants 
(Table 3). Higher education was associated with lower prevalence of reported difficulties with IADL, LEM, and LSA 
(Table 3). Higher income remained significantly associated with lower prevalence of disability among all measures. 
Fully adjusted models, including both income and education (r = 0.28, P < .001), showed that education was 
significant only for IADL disability: 14.2% for less than high school (reference group for P values), 11.8% (P = .02) for 
high school graduate, and 12.2% (P = .04) for more than high school. 
Sensitivity analyses  
Prevalence of disability was generally higher for older participants (≥65 y) and those with more severe CKD. The 
association of higher educational attainment with lower prevalence of LEM disability was significant only in 
participants aged 20 to 64, relative to those aged 65 years or older. Across all measures, the association of higher 
income with lower disability was strongest in the younger age group (data not shown). Disease severity did not modify 
the association of educational attainment and higher income with lower prevalence of disability. 
There was significantly greater LSA disability among older nonwhites relative to their white counterparts (non-
Hispanic blacks, 29.2%, vs non-Hispanic whites, 16.7%, and Mexican Americans, 19.3% vs non-Hispanic whites, 9.0%). 
The association gradient of higher education with lower prevalence of ADL disability remained consistent among 
populations (Table 4). However, people with CKD were, overall, 2 to 3 times as likely as those without CKD to report 
ADL disability. Regardless of comorbid conditions, the prevalence of ADL disability was higher among those with CKD. 
Among participants with no other conditions, ADL disability was 2 or more times as high in those with CKD and the 
lowest educational attainment as in those without. 
Discussion 
Disability, among a variety of domains, is prevalent in the US adult population with CKD. Lower educational 
attainment and lower income were strongly and consistently associated with higher prevalence of disability — that is, 
among all measures and independent of the other sociodemographic and clinical factors that we measured. Even in the 
presence of other conditions that can cause disability (eg, diabetes, CVD, cancer, arthritis), comorbid CKD confers a 
higher likelihood of disability, and this excess prevalence is greatest among people with lower educational attainment. 
Associations between CKD and SES (9,10,12,17) and between SES and disability (18) have been examined previously. 
However, to our knowledge, this is the first study to examine SES as a potential risk factor for disability among people 
with CKD, independent of minority race/ethnicity, older age, and the myriad comorbid conditions associated with 
prevalence of CKD and disability. 
We found that lower educational attainment and lower income, measured as either total income or as income relative 
to the federal poverty level (http://www.census.gov/hhes/www/poverty/data/threshld/index.html), were inversely 
related to all measures of disability. This linear association reinforces the presence of a powerful SES health gradient in 
which health outcomes are worse with lower income, regardless of whether income is above or below the poverty level 
(13,14,19). Additionally, in older adults, educational attainment was strongly associated with disability, as was lower 
income, suggesting the association is likely to be in the direction of SES to disability (vs disability to SES), because 
people with disability may have a subsequent loss in income but not in educational attainment. 
For people with CKD, lower SES may lead to disability through poor control of the conditions that cause CKD, 
particularly hypertension and diabetes, because of the person’s lack of understanding of the disease or the resources 
needed for adequate self-management and treatment. For example, poor blood pressure control, which is common 
among people with CKD (20,21), could lead to disability not just through stroke but through other systemic effects of 
hypertension (22). In diabetes-associated CKD, poor glycemic control may also lead to greater risk of disability; one 
study suggests that retinopathy and neuropathy, sequelae of poor glycemic control, were strong predictors of disability 
in African Americans with diabetes (23). We found that poor glycemic control did not change the association of 
education and income with disability in people with CKD and diabetes. Additionally, we showed that people whose 
CKD was complicated by diabetes and hypertension had higher rates of disability than those with diabetes and 
hypertension but no CKD, suggesting that CKD has an independent effect on disability prevalence beyond that 
conferred by these 2 etiologic factors. 
Environmental factors, including neighborhood effects (11,24), could also contribute to the observed disparities in 
disability among people with CKD. Personal psychosocial issues such as depression, which is prevalent among people 
with CKD (25) and less likely to be successfully treated in people with lower SES (26), may also lead to disability. 
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manual labor or carry increased risk of injury. This situation may partially explain why education affects LEM 
disability only in the younger (working) population. 
Adjustment for comorbidity and medication did not change the effect of education and income on disability, which 
suggests that these factors are unlikely to explain the associations. Inflammation, anemia, and level of physical activity 
also did not explain the association. In subgroup analyses, we found that income was more strongly associated with 
disability in younger (20-64 y) people. This supports the “reverse causality” scenario of decreased physical and mental 
functioning leading to lower income in people of working age through unemployment, early retirement, or disability. 
In general, there was little evidence that other sociodemographic factors modified the effect. 
In contrast to the associations seen with SES, adjustment for education and income nullified most of the associations 
of race/ethnicity with disability. The lack of effect of minority race/ethnicity may be due to lack of power in our study; 
such disparities in disability have been noted in other populations (27,28). However, this lack of effect may also 
suggest that biological differences that would lead to disparities in disability by race/ethnicity are unlikely and that 
social status, which is related to race/ethnicity for many, is a more important predictor of disability, at least among 
people with CKD. 
Our study has several limitations. First, because our study was cross-sectional, we cannot establish causality, despite 
strong indications of causality, including degree of association and consistency of association among measures. Some 
misclassification of disability and comorbid conditions is possible because these conditions are self-reported. 
Misclassification of CKD is also possible because of measurement error. The cross-sectional design did not allow 
assessment of lifetime socioeconomic status, which may be a better predictor of health outcomes than current income 
(29,30). Also, although CKD is generally a silent disease with few symptoms in its early phases, certain complications 
of CKD, such as anemia and uremia, could lead directly to disability. We were not able to examine the mechanism by 
which complications of early-stage CKD lead directly to disability because such complications were rare in our sample. 
Single assessments of eGFR and albuminuria likely led to misclassification of some participants as having chronic 
disease; however, any misclassification bias created would be toward the null. Additionally, Mexican Americans were 
treated as “not African American” in the calculation of eGFR, which may misclassify them, because the equations were 
developed for primarily white and black non-Hispanic populations. 
Despite these limitations, identifying a socioeconomic disparity in disability among people with CKD similar to 
disparities seen in non-CKD populations may be useful, because both disability and lower SES can worsen CKD 
outcomes. Because the disparities we identified were independent of age, race/ethnicity, and common comorbid 
conditions, our findings provide support for a prospective study of the relationship between socioeconomic status and 
subsequent development of disability among people with CKD. If the associations reported here were confirmed in a 
longitudinal study with appropriate causal inference, people with lower educational attainment or lower income who 
are at risk for CKD could be targeted for earlier identification and intervention to limit the development of disability 
and possible further loss of income due to disability. Further exploration of the mechanisms by which lower SES is 
associated with greater risk of disability among people with CKD is needed to identify effective interventions. 
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Characteristic % (95% CI)
Demographic
Age, y
20-39 15.8 (14.2-17.6)
40-59 29.4 (27.4-31.4)
60-69 16.4 (15.1-17.9)
≥70 38.4 (36.2-40.8)
Sex
Male 42.4 (40.8-44.0)
Female 57.6 (56.0-59.2)
Race/ethnicity
Non-Hispanic white 74.4 (71.2-77.4)
Non-Hispanic black 10.2 (8.6-12.1)
Mexican American 5.6 (4.4-7.0)
Socioeconomic
Education
Did not complete high school 28.0 (26.0-30.2)
High school graduate 26.7 (24.7-28.8)
Some college or college degree 45.3 (42.4-48.1)
Annual household income, $
<20,000 27.3 (24.9-30.0)
20,000-44,999 33.7 (31.5-36.0)
45,000-74,999 20.9 (18.7-23.3)
≥75,000 18.1 (15.7-20.7)
Percentage of federal poverty level
<100 14.7 (12.8-16.7)
100-399 57.9 (55.7-60.0)
a
a
b
c
d
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Country of birth
United States 87.8 (85.6-89.8)
Other 12.2 (10.3-14.4)
Marital status
Not married 45.0 (42.8-47.4)
Married 55.0 (52.7-57.3)
Health care access
Health insurance
No insurance 15.7 (13.6-18.1)
Public insurance 27.8 (25.1-30.6)
Private insurance 56.5 (53.6-59.4)
Routine site for health care
No 6.9 (5.7-8.3)
Yes 93.1 (91.7-94.3)
Clinical
Chronic kidney disease severity
Mild (stage 1 or 2) 47.3 (44.8-49.8)
Moderate to severe (stage 3 or 4) 52.7 (50.2-55.2)
Smoking
Sometimes or never 83.7 (82.1-85.3)
Every day 16.3 (14.7-18.0)
Obesity
Not obese (BMI <30 kg/m ) 61.1 (58.8-63.4)
Obese (BMI ≥30 kg/m ) 38.9 (36.6-41.2)
Diabetes
No 79.1 (77.1-80.9)
Yes 20.9 (19.1-22.9)
Hypertension
No 29.8 (28.0-31.7)
Yes 70.2 (68.3-72.0)
Cardiovascular disease
No 76.6 (74.6-78.5)
Yes 23.4 (21.5-25.4)
Cancer
No 84.0 (82.6-85.3)
Yes 16.0 (14.7-17.4)
Arthritis
No 57.7 (55.5-60.0)
Yes 42.3 (40.0-44.6)
e
2
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All factors were self-reported except chronic kidney disease (measured in spot urine [albumin:creatinine ratio] and serum 
[estimated glomerular function]) and obesity (measured during exam). 
 Mean age, 60.8 y (95% CI, 59.9-61.7). 
 Participants who listed their race/ethnicity as “other” were included in all analyses but are not presented here because of 
small sample sizes. 
 Federal poverty thresholds for each survey were defined per US Census estimates 
(http://www.census.gov/hhes/www/poverty/data/threshld/index.html). 
 Defined as mild (single albumin:creatinine ratio ³30 mg/g) or moderate to severe (estimated glomerular filtration rate 15-
59 mL/min/1.73 m ). 
  
Table 2. Prevalence  of Disability Among US Adults With Chronic Kidney 
Disease, by Demographic and Socioeconomic Characteristics, National 
Health and Nutrition Examination Survey, 1999-2008 
Characteristic
% With Disability 
ADL 
(95% CI)
P 
Value
IADL 
(95% CI)
P 
Value
LEM 
(95% CI)
P 
Value
LSA 
(95% CI)
P 
Value
Overall 19.9 (18.3-
21.5)
NA 25.9 (23.9-
28.0)
NA 50.0 (47.6-
52.4)
NA 20.6 (18.6-
22.8)
NA
Education
Did not complete high 
school
24.5 (22.1-
27.0)
<.001
34.0 (31.1-
37.1)
<.001
56.9 (53.3-
60.3)
<.001
26.2 (23.4-
29.3)
<.001
High school graduate 20.4 (19.0-
22.0)
26.6 (24.7-
28.6)
50.7 (48.4-
53.0)
21.1 (19.2-
23.2)
Some college or college 
degree
16.9 (15.0-
19.0)
20.3 (18.0-
22.8)
44.6 (41.7-
47.4)
16.8 (14.8-
19.0)
Annual household income, $
<20,000 28.8 (25.0-
31.4)
<.001
36.5 (33.0-
40.2)
<.001
61.2 (57.9-
64.3)
<.001
30.0 (26.8-
33.4)
<.001
20-44,999 20.8 (19.2-
22.4)
26.9 (24.8-
29.1)
51.9 (49.5-
54.2)
21.5 (19.5-
23.7)
45-74,999 15.0 (13.3-
16.8)
19.1 (17.0-
21.4)
42.4 (39.9-
45.0)
15.0 (13.1-
17.1)
≥75,000 10.6 (8.5-
13.0)
13.1 (10.8-
15.9)
33.5 (30.2-
37.0)
10.1 (8.2-
12.4)
Percentage of federal poverty level
<100 32.8 (28.4-
37.6)
<.001
41.3 (36.4-
46.3)
<.001
64.8 (60.7-
68.7)
<.001
35.3 (30.7-
40.3)
<.001
100-399 20.4 (18.8-
22.1)
26.7 (24.7-
28.9)
51.2 (48.8-
53.7)
21.3 (19.3-
23.5)
400 11.9 (10.1-
13.9)
15.9 (13.6-
18.6)
37.5 (34.4-
40.7)
11.8 (10.0-
14.0)
Country of birth
United States 20.3 (18.7-
22.0)
.56
26.6 (24.5-
28.8)
.05
50.8 (48.3-
53.3)
.01
21.3 (19.2-
23.5)
.03
Other 19.1 (15.7-
22.9)
21.8 (18.3-
25.7)
42.1 (36.5-
48.0)
16.7 (13.7-
20.3)
Race/ethnicity
Non-Hispanic white 19.4 (17.5- 25.6 (23.2- 50.9 (48.1- 20.6 (18.3-
a
b
c
d
e
2
a
bbbb
c
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extremity mobility; LSA, leisure and social activities. 
 Values are adjusted for age and sex. Disability defined as any difficulty reported in ADL (getting in and out of bed, using a 
fork, cup or knife, dressing oneself), IADL (managing money, house chores, preparing meals), LEM (walking 1 mile, walking 
up 10 steps, stooping, kneeling or crouching, walking between rooms on the same floor, standing up from an armless 
chair), or LSA (going to the movies, attending social events, leisure activity at home). 
 Indicates differences across categories (without trend), calculated from logistic regression models and marginal post-
estimation. 
 Federal poverty thresholds for each survey defined per the appropriate US Census estimates 
(http://www.census.gov/hhes/www/poverty/data/threshld/index.html). 
  
Table 3. Fully Adjusted  Prevalence of Disability Among US Adults With 
Chronic Kidney Disease, 1999-2008, by Education, Income, and 
Race/Ethnicity 
Abbreviations: CI, confidence interval; ADL, activities of daily living; IADL, instrumental activities of daily living; LEM, lower-
extremity mobility; LSA, leisure and social activities. 
 Values are adjusted for age, sex, race/ethnicity, routine site for health care, obesity, diabetes, hypertension, cancer, and 
21.5)
.01
28.2)
.06
53.6)
.93
23.2)
.19
Non-Hispanic black 22.6 (21.1-
24.2)
28.4 (26.5-
30.3)
51.0 (49.1-
52.9)
22.3 (20.6-
24.0)
Mexican American 26.2 (22.4-
30.3)
31.3 (27.0-
35.9)
51.1 (47.3-
54.9)
24.0 (20.5-
28.0)
Characteristic
% With Disability
ADL 
(95% CI)
P 
Value
IADL 
(95% CI)
P 
Value
LEM 
(95% CI)
P 
Value
LSA 
(95% CI)
P 
Value
Overall 18.3 (17.2-
19.3)
NA 24.5 (23.1-
25.9)
NA 44.2 (42.7-
45.6)
NA 19.2 (17.8-
20.7)
NA
Education
Did not complete high 
school
19.7 (17.5-
21.9)
.06
30.1 (27.6-
32.5)
<.001
47.6 (44.6-
50.6)
.003
22.5 (20.0-
25.0)
<.001
High school graduate 19.1 (16.6-
21.6)
23.2 (20.6-
25.7)
44.1 (41.4-
53.0)
18.9 (16.4-
21.4)
Some college or college 
degree
16.5 (14.7-
18.4)
21.2 (18.8-
23.5)
41.9 (39.6-
44.1)
16.8 (14.8-
18.8)
Annual household income, $
<20,000 23.1 (20.5-
31.4)
<.001
31.3 (28.7-
33.8)
<.001
49.8 (46.4-
53.1)
<.001
24.8 (21.8-
27.8)
<.001
20-44,999 18.2 (15.5-
20.9)
24.3 (21.3-
27.4)
46.8 (44.1-
49.4)
20.1 (17.0-
23.2)
45-74,999 14.3 (11.5-
17.1)
19.0 (15.3-
22.7)
37.6 (34.0-
41.3)
14.4 (11.6-
17.2)
≥75,000 11.6 (8.4-
14.8)
14.9 (11.4-
18.4)
34.6 (31.2-
37.9)
10.1 (7.5-
12.8)
Race/ethnicity
Non-Hispanic white 17.7 (16.4-
19.2)
.009
24.2 (22.4-
26.0)
.05
51.0 (49.2-
52.9)
.84
19.1 (17.3-
20.9)
.14
Non-Hispanic black 22.0 (18.8-
25.2)
28.1 (24.4-
31.7)
46.6 (43.6-
49.5)
22.3 (20.6-
25.9)
Mexican American 22.6 (22.4-
30.3)
27.8 (23.3-
32.3)
44.9 (41.7-
48.1)
20.8 (16.9-
24.8)
a
b
c
a
bbbb
a
Page 10 of 11 CDC - Preventing Chronic Disease: Volume 9, 2012: 11_0052For Questions About This Article Contact pcdeditor@cdc.gov 
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 
30333, USA 
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, New Hours of 
Operation 8am-8pm ET/Monday-Friday 
Closed Holidays - cdcinfo@cdc.gov 
Page last reviewed: January 19, 2012  
Page last updated: January 19, 2012  
Content source: National Center for Chronic Disease Prevention and Health Promotion  
arthritis. Disability was defined as any difficulty reported in ADL (getting in and out of bed, using a fork, cup or knife, 
dressing oneself), IADL (managing money, house chores, preparing meals), LEM (walking 1 mile, walking up 10 steps, 
stooping, kneeling or crouching, walking between rooms on the same floor, standing up from an armless chair), or LSA 
(going to the movies, attending social events, leisure activity at home). 
 Indicates differences across categories (without trend), calculated from logistic regression models and marginal post-
estimation. 
  
Table 4. Age- and Sex-Adjusted Prevalence of Disability Related to Activities 
of Daily Living Among US Adults With and Without Chronic Kidney Disease, 
National Health and Nutrition Examination Survey, 1999-2008 
Abbreviations: ADL, activities of daily living; CI, confidence interval. 
 Population without chronic kidney disease consists of 16,898 adults aged ≥20 y who have available laboratory 
measurements to define disease, have an estimated glomerular filtration rate of ≥60 mL/min/1.73 m , have a urine 
albumin:creatinine ratio of <30 mg/g, and are not pregnant. 
 None of the conditions listed above.  
Comorbid 
Condition
Age- and Sex-Adjusted % With ADL Disability (95% CI)
With Chronic Kidney Disease (n = 4,257)
Without Chronic Kidney Disease (n = 
16,898)
<High 
School High School
>High 
School
<High 
School High School
>High 
School
Overall 24.5 (22.1-
27.0)
20.4 (19.0-
22.0)
16.9 (15.0-
19.0)
11.3 (10.2-
12.4)
7.9 (7.3-8.5) 5.4 (4.8-6.0)
Diabetes 35.7 (30.4-
41.4)
34.1 (30.6-
37.7)
32.4 (26.9-
38.5)
23.3 (18.6-
28.7)
18.7 (15.7-
22.2)
14.9 (11.4-
19.2)
Hypertension 26.7 (24.3-
29.2)
23.4 (21.9-
24.9)
20.3 (18.1-
22.8)
17.8 (15.8-
20.1)
12.7 (11.7-
13.9)
8.9 (7.8-10.2)
Cardiovascular 
disease
37.7 (33.0-
42.7)
33.7 (30.8-
36.8)
30.0 (25.3-
35.0)
33.5 (28.3-
39.0)
26.3 (23.3-
29.5)
20.1 (16.4-
24.5)
Cancer 30.3 (22.7-
39.3)
26.1 (21.4-
31.4)
22.3 (17.9-
27.4)
22.0 (17.2-
27.7)
16.0 (13.6-
18.7)
11.4 (9.2-
14.0)
Arthritis 36.9 (33.1-
40.8)
33.0 (30.7-
35.4)
29.4 (26.0-
33.1)
30.6 (27.5-
33.9)
23.5 (21.8-
25.4)
17.7 (15.5-
20.1)
None 10.0 (4.6-
20.5)
4.6 (2.6-7.9) 2.0 (1.0-4.2) 3.6 (2.8-4.7) 2.4 (2.0-2.9) 1.6 (1.2-2.1
b
a
b
a
2
b
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